VITAS Healthcare Expands Hospital-Based Inpatient Hospice Center Chemed Corp. (NYSE: CHE) VITAS Healthcare recently expanded its inpatient hospice care unit at the Florida-based Broward Health Medical Center. The inpatient facility now has 12 patient beds, up from eight prior to the renovations. VITAS expects to serve roughly 550 patients annually at the center. “VITAS is […]
After the tumultuous years of the pandemic, VITAS Healthcare expects a stable growth trajectory heading into 2024. Florida-based VITAS is a subsidiary of Chemed Corp. (NYSE: CHE). Though the company has not yet released financial guidance for 2024, VITAS anticipates a “predictable” year in terms of earnings and growth, executives said at Monday’s Bank of […]
Investment trends in the hospice industry have meandered in recent years, impacting providers’ approaches to growth in 2024. The mix of hospice buyers has become more diverse during the past five years to include more private equity investors, large health and hospital systems and home health companies, along with payers. These trends will have lasting […]
The benefits of advance care planning for seniors are well-documented, but younger adults should also ensure they are prepared for a life-threatening health crisis, according to Dr. Joseph Shega, executive vice president and chief medical officer for VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHEM). Data from some studies indicate that higher completion rates […]
VITAS Healthcare, a subsidiary of of Chemed Corp. (NYSE: CHE), has brought up from its ranks three new executive leaders. Meanwhile, its parent company Chemed has named a new CFO. As of 2020, Miami-based VITAS is the nation’s largest hospice provider by market share, operating 50 locations in 14 states. Through the third quarter of […]
With burnout as a major cause of turnover, hospices are applying technology to take some of the pressure off of staff in hopes of boosting retention. A frequent goal is reducing the amount of time spent on documentation. Though complete and accurate documentation is essential to regulatory compliance, patient safety and securing payment, the sheer […]
Though its temporary bonus program has ended, VITAS Healthcare has built on the momentum it created with accelerated hiring and corresponding gains in capacity. VITAS is a subsidiary of Chemed Corp. (NYSE: CHE). The bonus program, which ended in July, included a one-time retention payment that ranges from $2,000 to $15,000 per employee for nurses, […]
Amedisys’ New Chief Accounting Officer The forthcoming acquisition of Amedisys, Inc. (NASDAQ: AMED) by UnitedHealth Group (NYSE: UNH) subsidiary Optum has sparked executive shifts. The home health and hospice provider recently announced the leadership changes in a filing with the U.S. Securities & Exchange Commission (SEC). Allyson Guidroz was recently appointed as its chief accounting […]
Rising regulatory scrutiny around length of stay may be having adverse impacts on health care costs and quality, hospice leaders said in a recent Congressional briefing. Fear of regulatory attention, audits or post-payment reviews related to longer stays could drive some hospice providers to discharge patients who can still benefit from their services, according to […]
Workforce and patient census are rebounding for the Chemed Corp. (NYSE: CHE) subsidiary VITAS Healthcare, but financial pressure points remain. The gains have come with significant effort and costs, including the roll out of its recruitment and retention bonus program last July. Since then, the hospice provider has seen sequential improvements during the last four […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
